Inicio › Diabetes tipo 1 › Pensilvania
Ensayos clínicos de Diabetes tipo 1 en Pensilvania
13 estudios sobre Diabetes tipo 1 buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Children's Hospital of Philadelphia (CHOP), Philadelphia
ReclutandoFase 3
Edades de 1 a 35 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
ReclutandoFase 3
Edades de 1 a 35 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia
ReclutandoFase 3
Edades de 1 a 25 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07088068Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Pittsburgh, Pittsburgh
ReclutandoFase 2
Edades de 4 a 34 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Pittsburgh, Pittsburgh
ReclutandoFase 2
Edades de 8 a 45 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Pittsburgh, Pittsburgh
ReclutandoFase 1/2
Edades de 9 a 20 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center Montefiore, Pittsburgh
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 1 sept 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- The Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
ReclutandoFase 2
Edades de 5 a 40 · Todos los sexos · Actualizado el 24 ago 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Pennsylvania, Philadelphia
Reclutando
Edades de 18 a 65 · Todos los sexos · Actualizado el 16 jul 2026 · NCT06880835Registry for Stage 2 Type 1 Diabetes
- Hospital of The University of Pennsylvania- Site Number : 8400021, Philadelphia
- The Children's Hospital of Philadelphia- Site Number : 8400029, Philadelphia
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 13 abr 2026 · NCT06481904An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Perelman Center for Advanced Medicine - Endocrinology, Philadelphia
- Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 23 mar 2026 · NCT06832410Closed Loop and Education for Hypoglycemia Awareness Restoration
- University of Pennsylvania, Philadelphia
Reclutando
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 mar 2026 · NCT06325202TrialNet Pathway to Prevention of T1D
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 2 a 45 · Todos los sexos · Actualizado el 1 jul 2025 · NCT00097292De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.